Liver ASK1 protects from non‐alcoholic fatty liver disease and fibrosis-Reference-Cited by-同舟云学术

Liver ASK1 protects from non‐alcoholic fatty liver disease and fibrosis

Published:2019-06-06 Issue:10 Volume:11 Page:
ISSN:1757-4676
Container-title:EMBO Molecular Medicine
language:en
Short-container-title:EMBO Mol Med

Author:

Challa Tenagne D¹²,Wueest Stephan¹²,Lucchini Fabrizio C¹²³,Dedual Mara¹²³,Modica Salvatore⁴,Borsigova Marcela¹²,Wolfrum Christian⁴,Blüher Matthias⁵,Konrad Daniel¹²³^ORCID

Affiliation:

1. Division of Pediatric Endocrinology and Diabetology University Children's Hospital Zurich Switzerland

2. Children's Research Center University Children's Hospital Zurich Switzerland

3. Zurich Center for Integrative Human Physiology University of Zurich Zurich Switzerland

4. Institute of Food, Nutrition and Health ETH Zurich Schwerzenbach Switzerland

5. Department of Medicine University of Leipzig Leipzig Germany

Funder

Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung

Publisher

EMBO

Subject

Molecular Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.15252/emmm.201810124

Reference70 articles.

1. Autophagy in liver diseases: Time for translation?

2. The lipogenic transcription factor ChREBP dissociates hepatic steatosis from insulin resistance in mice and humans

3. Antagonism of the chemokine Ccl5 ameliorates experimental liver fibrosis in mice

4. p62/SQSTM1 forms protein aggregates degraded by autophagy and has a protective effect on huntingtin-induced cell death

5. Mouse Models for miRNA Expression: The ROSA26 Locus

Cited by 65 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Decreasing the burden of non-alcoholic fatty liver disease: From therapeutic targets to drug discovery opportunities;European Journal of Medicinal Chemistry;2024-11

2. The current landscape of antifibrotic therapy across different organs: A systematic approach;Pharmacological Research;2024-07

3. Targeting ASK1 by CS17919 alleviates kidney‐ and liver‐related diseases in murine models;Animal Models and Experimental Medicine;2024-06-14

4. New and emerging treatments for metabolic dysfunction-associated steatohepatitis;Cell Metabolism;2024-05

5. Lycopene Alleviates Endoplasmic Reticulum Stress in Steatohepatitis through Inhibition of the ASK1–JNK Signaling Pathway;Journal of Agricultural and Food Chemistry;2024-03-28